S21-363 Neuroprotective Gene Therapy for Glaucoma The Hu Lab at Stanford has developed a neuroprotective gene therapy for treating glaucoma and other optic neuropathies. Their gene therapy AAV vector expresses NMNAT2 operably linked to a retinal ganglion cell-specific promoter (mSngc). Yang Hu
S21-124 New Tools and Molecular Target for Gene Therapy of Chronic Pain Researchers at Stanford have developed non-opiate methods for treating chronic pain and for retrograde transduction of neurons. Xiaoke Chen Qian Wang Gregory Nachtrab